← Leaderboards
I Ross Garrett
Osteoscreen, Inc.
$398,950
Attributed
$398,950
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$398,950 · 4
By mechanism
R43$398,950 · 4
Top collaborators
No co-investigators on record.
Most similar at Osteoscreen, Inc.
Same institution · by research overlap
- Di Chen$7,329,099
- Wolfgang E Gallwitz$99,309
- Gloria Gutierrez$99,882
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationNeoplasm /Cancer ChemotherapyLaboratory MouseHistologyAntineoplasticsPharmacokineticsBreast NeoplasmsCharge Coupled Device CameraCytotoxicityDosageDrug Design /Synthesis /ProductionEnzyme Linked Immunosorbent AssayGreen Fluorescent ProteinsHmg Coa ReductasesHypercalcemiaLaboratory RatLovastatinMetastasisMineralsMorphometryMultiple MyelomaMusculoskeletal Disorder TherapyNeoplasm /Cancer PharmacologyNeoplastic Process
Grant awards (4)
Novel Bisphosphonate Conjugates in Myeloma Bone Disease$99,171
R43 · FY2005 · CA
Preclinical Efficacy of Epoxomicin in Multiple Myeloma$99,974
R43 · FY2003 · CA
LOW DOSE 6-THIOGUANINE FOR OSTEOLYTIC BONE DISEASE$100,000
R43 · FY2000 · AR
TOPICAL APPLICATION OF STATINS FOR OSTEOPOROSIS$99,805
R43 · FY2000 · AG